NCT05908617 (VID-HF) is a NA clinical trial of Video Discharge in Heart Failure, sponsored by Yasmeen Golzar.

Who is sponsoring NCT05908617?

NCT05908617 is sponsored by Yasmeen Golzar.

What drugs are being tested in NCT05908617?

Interventions in NCT05908617: Video Discharge.

What condition does NCT05908617 study?

NCT05908617 studies Heart Failure.

Is NCT05908617 still recruiting?

NCT05908617 is currently withdrawn. Last updated 18 June 2023.

Last reviewed 2023-06-18 · How we verify

NCT05908617: VID-HF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Video Discharge Instructions on Heart Failure Patient's Knowledge

Withdrawn NA Last updated 18 June 2023

What this trial tests

NA trial testing Video Discharge in Heart Failure. Withdrawn.

Timeline

1 May 2018

Primary endpoint
7 July 2018

7 August 2018

Quick facts

Lead sponsor	Yasmeen Golzar
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Start date	1 May 2018
Primary completion	7 July 2018
Estimated completion	7 August 2018
Sites	1 location across United States

Drugs / interventions tested

Video Discharge

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

Yasmeen Golzar

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With improve care of patients with heart failure, many patients are living longer. Care for these patients is now not only focused on mortality but also on the quality of life. Patient knowledge about heart failure and their overall compliance with the necessary lifestyle changes will lead to an improved quality of life. Discovering alternative ways to improve patient knowledge is key to long term survival. This studies objective is to assess the overall impact of video discharge instructions as compared to paper discharge instructions on Heart Failure Knowledge among an under-served patient population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05908617 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yasmeen Golzar
Last refreshed: 18 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05908617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing